Gilead Sciences Inc Capital Reinvestment Ratio
Gilead Sciences Inc capital reinvestment ratio. Gilead Sciences Inc (GILD) has a Capital Reinvestment Ratio of 0.03x as of June 2026, meaning it reinvests 0% of its operating cash flow ($3.57 Billion) in capital expenditures ($117.00 Million). Check GILD capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Gilead Sciences Inc (2002–2025)
Capital reinvestment ratio of Gilead Sciences Inc from 2002 to 2025. This chart tracks Gilead Sciences Inc's Capital Reinvestment Ratio across 24 annual periods. Also explore how fast is Gilead Sciences Inc growing its equity to track the company's year-over-year net asset growth rate.
Gilead Sciences Inc Capital Reinvestment Ratio by Year (2002–2025)
Gilead Sciences Inc capital reinvestment ratio by year from 2002 to 2025. For the full cash flow conversion analysis, see Gilead Sciences Inc operating cash flow efficiency.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.06x | $10.02 Billion | $563.00 Million | ▲ +16.3% |
| 2024 | 0.05x | $10.83 Billion | $523.00 Million | ▼ -33.9% |
| 2023 | 0.07x | $8.01 Billion | $585.00 Million | ▼ -8.9% |
| 2022 | 0.08x | $9.07 Billion | $728.00 Million | ▲ +57.8% |
| 2021 | 0.05x | $11.38 Billion | $579.00 Million | ▼ -36.1% |
| 2020 | 0.08x | $8.17 Billion | $650.00 Million | ▼ -11.8% |
| 2019 | 0.09x | $9.14 Billion | $825.00 Million | ▼ -18.0% |
| 2018 | 0.11x | $8.40 Billion | $924.00 Million | ▲ +121.8% |
| 2017 | 0.05x | $11.90 Billion | $590.00 Million | ▲ +13.0% |
| 2016 | 0.04x | $17.05 Billion | $748.00 Million | ▲ +24.8% |
| 2015 | 0.04x | $21.25 Billion | $747.00 Million | ▼ -19.1% |
| 2014 | 0.04x | $12.82 Billion | $557.00 Million | ▼ -29.0% |
| 2013 | 0.06x | $3.10 Billion | $190.00 Million | ▼ -50.8% |
| 2012 | 0.12x | $3.19 Billion | $397.00 Million | ▲ +242.8% |
| 2011 | 0.04x | $3.64 Billion | $131.90 Million | ▲ +66.0% |
| 2010 | 0.02x | $2.83 Billion | $61.88 Million | ▼ -70.8% |
| 2009 | 0.07x | $3.08 Billion | $230.06 Million | ▲ +39.2% |
| 2008 | 0.05x | $2.14 Billion | $115.00 Million | ▲ +20.4% |
| 2007 | 0.04x | $1.77 Billion | $78.65 Million | ▼ -48.4% |
| 2006 | 0.09x | $1.22 Billion | $105.21 Million | ▲ +27.1% |
| 2005 | 0.07x | $705.64 Million | $47.95 Million | ▼ -32.8% |
| 2004 | 0.10x | $507.96 Million | $51.37 Million | ▼ -38.6% |
| 2003 | 0.16x | $234.61 Million | $38.61 Million | ▼ -30.4% |
| 2002 | 0.24x | $74.41 Million | $17.60 Million | — |